Staci Williamson

533 total citations
7 papers, 20 citations indexed

About

Staci Williamson is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Staci Williamson has authored 7 papers receiving a total of 20 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Molecular Biology and 1 paper in Organic Chemistry. Recurrent topics in Staci Williamson's work include CAR-T cell therapy research (4 papers), Glycosylation and Glycoproteins Research (1 paper) and Pneumocystis jirovecii pneumonia detection and treatment (1 paper). Staci Williamson is often cited by papers focused on CAR-T cell therapy research (4 papers), Glycosylation and Glycoproteins Research (1 paper) and Pneumocystis jirovecii pneumonia detection and treatment (1 paper). Staci Williamson collaborates with scholars based in United States and Canada. Staci Williamson's co-authors include D.A. Kuntz, David R. Rose, John J. Naleway, Levanto Schachter, Daniel J. Coleman, Brandon Hayes‐Lattin, Richard T. Maziarz, Meenakshi Venkatesan, Joseph P. McGuirk and Andy Kaempf and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Analytical Biochemistry.

In The Last Decade

Staci Williamson

7 papers receiving 20 citations

Peers

Staci Williamson

ONCOL

MB

BE

SPECT

OC

Norain Ab. Latif Malaysia

Amar Rahi United Kingdom

Jenny Lin United States

Alastair Magness United Kingdom

Curtis Sheldon United States

Yohana Ghebrechristos United States

Gopalakrishnan Natarajan United States

Rouven Hoefflin Germany

Devin McAvoy United States

Ana Nogués Pevidal Spain

Norain Ab. Latif Malaysia

Staci Williamson

8 ×0.8

ONCOL

7 ×0.9

MB

5 ×0.6

BE

0 ×0.0

SPECT

0 ×0.0

OC

Citations per year, relative to Staci Williamson Staci Williamson (= 1×) peers Norain Ab. Latif

Countries citing papers authored by Staci Williamson

Since Specialization

Citations

This map shows the geographic impact of Staci Williamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Staci Williamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Staci Williamson more than expected).

Fields of papers citing papers by Staci Williamson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Staci Williamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Staci Williamson. The network helps show where Staci Williamson may publish in the future.

Co-authorship network of co-authors of Staci Williamson

This figure shows the co-authorship network connecting the top 25 collaborators of Staci Williamson. A scholar is included among the top collaborators of Staci Williamson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Staci Williamson. Staci Williamson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Desai, Amrita, Cristian D. Valenzuela, Brandon Hayes‐Lattin, et al.. (2025). Real World Experience of a Single-Center Tumor Infiltrating Lymphocyte (TIL) Melanoma Therapy Program: primary referral to TIL infusion (Brain to Vein). Cytotherapy. 27(5). S171–S172. 1 indexed citations

2.

Williamson, Staci, Levanto Schachter, Andy Chen, et al.. (2024). Sociodemographic Factors Influencing Access to Chimeric Antigen T-Cell Receptor Therapy for Patients With Non-Hodgkin Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 25(2). e120–e125. 4 indexed citations

3.

Williamson, Staci, Jamie Brower, Veronika Bachanová, et al.. (2023). Prolonged Cytopenias after Commercial CAR T-Cell Therapy with Tisagenlecleucel and Axicabtagene Ciloleucel for Relapsed and Refractory DLBCL. Transplantation and Cellular Therapy. 29(2). S220–S221. 1 indexed citations

4.

Williamson, Staci, Rebecca Silbermann, Eva Medvedova, et al.. (2021). Second Autologous Stem Cell Transplant as Salvage in Multiple Myeloma – The Oregon Health and Science University Experience. Clinical Lymphoma Myeloma & Leukemia. 22(2). 105–112. 1 indexed citations

5.

Gauthier, Jordan, Paula Perkins, Mazyar Shadman, et al.. (2021). CD19 CAR T-cell product type independently impacts CRS and ICANS severity in patients with aggressive NHL.. Journal of Clinical Oncology. 39(15_suppl). 7532–7532. 3 indexed citations

6.

Saultz, Jennifer N., Andy Kaempf, Guang Fan, et al.. (2020). Early Infection after Allogeneic Transplant Increases NRM without Influencing Relapse Rate. Blood. 136(Supplement 1). 21–21. 1 indexed citations

7.

Coleman, Daniel J., D.A. Kuntz, Meenakshi Venkatesan, et al.. (2009). A long-wavelength fluorescent substrate for continuous fluorometric determination of α-mannosidase activity: Resorufin α-d-mannopyranoside. Analytical Biochemistry. 399(1). 7–12. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact